Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Merck
Express Scripts
Baxter
McKinsey

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

Us Army Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for US ARMY, and what generic and branded alternatives to US ARMY drugs are available?

US ARMY has seven approved drugs.



Summary for Us Army
US Patents:0
Tradenames:7
Ingredients:7
NDAs:7

Drugs and US Patents for Us Army

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Army DIAZEPAM diazepam INJECTABLE;INJECTION 020124-001 Dec 5, 1990 DISCN No No   Start Trial   Start Trial
Us Army PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET;ORAL 020414-001 Feb 5, 2003 DISCN No No   Start Trial   Start Trial
Us Army Walter Reed MEFLOQUINE HYDROCHLORIDE mefloquine hydrochloride TABLET;ORAL 019578-001 May 2, 1989 DISCN No No   Start Trial   Start Trial
Us Army SODIUM THIOSULFATE sodium thiosulfate INJECTABLE;INJECTION 020166-001 Feb 14, 1992 DISCN No No   Start Trial   Start Trial
Us Army ATNAA atropine; pralidoxime chloride INJECTABLE;INTRAMUSCULAR 021175-001 Jan 17, 2002 DISCN No No   Start Trial   Start Trial
Us Army ATROPINE SULFATE atropine sulfate AEROSOL, METERED;INHALATION 020056-001 Sep 19, 1990 DISCN No No   Start Trial   Start Trial
Us Army SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS perfluoropolymethylisopropyl ether; polytetrafluoroethylene PASTE;TOPICAL 021084-001 Feb 17, 2000 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Baxter
Dow
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.